These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2702343)

  • 41. Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.
    Pugliese A
    J Clin Invest; 2003 May; 111(9):1280-2. PubMed ID: 12727917
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of suppurative wounds in patients with diabetes mellitus].
    Nuzov BG; Smoliagin AI; Chaínikova IN; Livshits NM; Anisimova TM; Nuzova TV
    Khirurgiia (Mosk); 1997; (8):16-9. PubMed ID: 9480372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New possibilities and perspectives in the treatment of juvenile diabetes].
    Vavrinec J; Kopecký A
    Cesk Pediatr; 1982 Nov; 37(11):649-52. PubMed ID: 6756654
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunological prospects in the treatment of type 1 diabetes mellitus].
    Boitard C; Larger E
    Rev Prat; 1996 Mar; 46(5):593-7. PubMed ID: 8815526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of type 1 diabetes in mice.
    Faustman DL
    N Engl J Med; 2007 Jan; 356(3):311-2. PubMed ID: 17229964
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat.
    Popovic J; Kover KL; Moore WV
    Pediatr Diabetes; 2004 Mar; 5(1):3-9. PubMed ID: 15043683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
    Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cyclosporin A and diabetes type I].
    Timsit J; Boitard C; Warnet A
    Rev Infirm; 1988 Feb; 38(3):27-30. PubMed ID: 3153531
    [No Abstract]   [Full Text] [Related]  

  • 49. Vaccination studies in type 1 diabetes.
    Buschard K; Funda DP
    Lancet; 2002 Aug; 360(9331):488; author reply 488. PubMed ID: 12241742
    [No Abstract]   [Full Text] [Related]  

  • 50. [General principles of intensified conventional insulin therapy of type I diabetes].
    Andĕl M; Slabochová Z; Dryáková M; Andĕlová K; Vondra K; Bartos V
    Vnitr Lek; 1987 Jun; 33(6):475-85. PubMed ID: 3310386
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of cyclosporine A on humoral and cellular immunity in insulin-dependent (type I) diabetes mellitus.
    Boitard C; Debray-Sachs M; Chatenoud L; Bach JF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):193-6. PubMed ID: 3289205
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of immunotherapy in type I diabetes mellitus.
    Geffner ME; Lippe BM
    West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy in type 1 diabetes.
    Pozzilli P
    Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
    [No Abstract]   [Full Text] [Related]  

  • 54. Chairman's summary. Antigen processing, presentation, and immunomodulation.
    Lamb JR
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 2):S138-40. PubMed ID: 11029382
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune intervention therapy in type 1 diabetes: safety first.
    Roep BO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):263-5. PubMed ID: 24622405
    [No Abstract]   [Full Text] [Related]  

  • 56. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?
    Blajchman MA
    Transfusion; 1999 Jul; 39(7):665-70. PubMed ID: 10413271
    [No Abstract]   [Full Text] [Related]  

  • 57. IMMUNOMODULATION - CLINICAL APPLICATIONS.
    Dham SK
    Med J Armed Forces India; 1995 Jul; 51(3):149-150. PubMed ID: 28769276
    [No Abstract]   [Full Text] [Related]  

  • 58. On the Principles of the Treatment of Diabetes Mellitus.
    Pavy FW
    Ind Med Gaz; 1890 Nov; 25(11):327-330. PubMed ID: 29000506
    [No Abstract]   [Full Text] [Related]  

  • 59. [Principles and perspectives of immunomodulation in the treatment of diabetes mellitus type I].
    Majkowska L; Czekalski S
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):509-12. PubMed ID: 2702343
    [No Abstract]   [Full Text] [Related]  

  • 60. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.